
Lifesaving bedside stroke test receives UK product safety mark
A revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.
Read moreA revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.
Read moreA major UK study has discovered that the disturbed sleep patterns in patients hospitalised with COVID-19 was likely to be a driver of breathlessness.
Read moreThe NIHR has awarded more than £96 million to 93 NHS organisations as part of a capital investment – with £2.26 million awarded to MFT.
Read moreA new platform has been announced, bringing together UK strengths in rare diseases research to improve diagnosis and treatment.
Read moreManchester researchers have developed a way to improve the accuracy of breast cancer genetic testing for women from Ashkenazi Jewish backgrounds.
Read moreUniversity of Manchester Chancellor Nazir Afzal OBE has become the 1,000th person in Greater Manchester to take part in a huge research project.
Read moreThe Mayor of Greater Manchester, Andy Burnham, officially opened a successful launch event to celebrate the multi-million-pound funding boost for the NIHR Manchester BRC and CRF
Read moreGreater Manchester health and care partners announce new multi-million pound health innovation accelerator focused on rapidly improving the diagnosis and treatment of disease across 2,8m GM population
Read more